Caire Companion 5 Home Oxygen Concentrator
CAIRE Companion 5 Home Oxygen Concentrator with O2 Monitor
Continuous Flow (0.5ā5.0 LPM)
~40 dBA @ 2 LPM (ultraSILENT)
2-Year Service Cycle
Executive Product Overview
The CAIRE Companion 5 is a compact, clinical-grade stationary home oxygen concentrator engineered to deliver steady, continuous-flow oxygen from 0.5 to 5.0 LPM. Designed for long-term care facilities, home health setups, and clinical bed environments, it provides dependable 24/7 respiratory therapy through standard wall outlet power.
This model features CAIRE's integrated Oxygen Sensing Device (OCSI) monitor, which continuously tracks output purity and triggers visual and audible alerts if oxygen concentration falls below 85%. Powered by autoFLOW technology, the Companion 5 maintains low power consumption (under 300W at 3 LPM) and operates at an ultraSILENT ~40 dBA noise level, minimizing disruption during nighttime therapy while reducing operational energy costs for care facilities.
Key Performance & Safety Features
- 0.5 to 5.0 LPM Continuous Flow: Smooth, adjustable flow gauge supports diverse long-term oxygen therapy protocols.
- Integrated OCSI Oxygen Monitor: Solid-state sensor continuously verifies purity and alarms if concentration drops below 85%.
- ultraSILENT Operation (~40 dBA): Exceptionally quiet sound profile supports undisturbed overnight patient sleep.
- autoFLOW Energy Efficiency: Advanced flow control minimizes power draw to under 300W at 3 LPM.
- Comprehensive Alarm System: Automated warnings for power failure, high/low pressure, low purity, and temperature faults.
- Front-Access Humidifier Cradle: Integrated recessed stand securely holds standard humidifier bottles (sold separately).
- Low Maintenance Cycle: Commercial-grade components require intake filter service only once every 2 years.
Complete Technical Specifications
| Brand / Manufacturer | CAIRE Inc. |
|---|---|
| Model Designation | Companion 5 (with OCSI Oxygen Monitor) |
| Product Classification | Stationary Home Oxygen Concentrator |
| FDA Regulatory Status | Class II Medical Device | Prescription (Rx) Required |
| Flow Range & Delivery | 0.5 to 5.0 LPM Continuous Flow |
| Oxygen Concentration | 90% (+5.5% / -3.0%) at all flow rates |
| Purity Monitor (OCSI) | Included ā Triggers alarm below 85% purity |
| Sound Level | ~40 dBA at 2 LPM |
| Power Requirements | 120 VAC / 60 Hz (~285W Avg @ 3 LPM; 350W Max) |
| Max Cannula Tubing Run | 50 feet (15.2 meters) |
| Dimensions & Weight | 21.5ā³ H x 12.5ā³ W x 13.5ā³ D | Net Weight: ~36 lbs (16.3 kg) |
| Service & Warranty | 2-Year Filter Maintenance | 3-Year Limited Warranty |
Facility Procurement & Risk Mitigation Insight
Standardizing facility bed spaces on the CAIRE Companion 5 reduces operational power overhead via autoFLOW technology while mitigating clinical compliance risks through the built-in OCSI monitor. The extended 2-year maintenance interval lowers staff service touchpoints, making it an efficient asset for institutional respiratory fleets.
Product & Compliance FAQs
Q: How does the built-in OCSI oxygen monitor enhance patient safety?
A: The OCSI monitor continuously measures output purity in real time. If oxygen concentration drops below 85%, the system immediately triggers visual and audible alerts, giving clinical staff immediate verification without manual spot-check meters.
Q: What routine maintenance is required for the CAIRE Companion 5?
A: The Companion 5 features a low-maintenance design that only requires gross particle filter cleaning and air intake filter replacement every 2 years, reducing fleet maintenance downtime.
Q: What prescription documentation is required prior to shipping?
A: Per FDA Class II medical device regulations, orders for the CAIRE Companion 5 require a valid prescription or medical license verification prior to order release.
B2B Procurement Disclaimer: Technical specifications, flow ratings, and regulatory guidelines are compiled from CAIRE manufacturer standards. Facilities are responsible for verifying valid prescription documentation prior to patient deployment.
ā WARNING: This product can expose you to chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm. For more information go to www.P65Warnings.ca.gov.